AMIKACIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amikacin, and when can generic versions of Amikacin launch?
Amikacin is a drug marketed by Abbott, Avet Lifesciences, Fresenius Kabi Usa, Hikma, Hospira, Igi Labs Inc, Meitheal, Qilu, and Sagent Pharms Inc. and is included in twenty-one NDAs.
The generic ingredient in AMIKACIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amikacin
A generic version of AMIKACIN was approved as amikacin sulfate by MEITHEAL on September 28th, 1993.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMIKACIN?
- What are the global sales for AMIKACIN?
- What is Average Wholesale Price for AMIKACIN?
Summary for AMIKACIN
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 21 |
| Drug Prices: | Drug price information for AMIKACIN |
| DailyMed Link: | AMIKACIN at DailyMed |
US Patents and Regulatory Information for AMIKACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 063265-001 | Nov 30, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Igi Labs Inc | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 063169-001 | Dec 14, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 063313-001 | Apr 11, 1994 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 205605-001 | Dec 9, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 063283-001 | Oct 31, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Meitheal | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 064045-002 | Sep 28, 1993 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 063275-001 | May 18, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
